Immunohematology Market by Product, End-user and Geography- Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 160 SKU: IRTNTR45886

Immunohematology Market Forecast 2023-2027

The immunohematology market size is estimated to grow by USD 1.27 billion at a CAGR of 9.06% between 2022 and 2027. 

There is an increasing shift by end-users to automated immunohematology analyzers in the global market. Several manufacturers in the market are increasingly focusing on developing automated and semi-automated immunohematology analyzers that can minimize the requirement for manual methods and help reduce human errors. Additionally, there is an increasing demand for  semi- and fully-automated immunohematology analyzers in the market due to the growing need for blood transfusions for different surgical procedures. The blood banks and hospitals constitute a huge quantity of blood units, which need regular screening. Hence, Tier 1 companies such as Immucor, Grifols, and Ortho Clinical Diagnostics have launched automated immunology analyzers that can meet the demand of different end-users as well as minimize staff and human errors. Hence, such factors are expected to positively impact the market growth.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by Product, End-user, and Geography Analysis

This report extensively covers immunohematology market segmentation by product (analyzers and systems and reagents) and geography (North America, Europe, Asia, and ROW).

Product Analysis 

The analyzers and systems segment is estimated to witness significant growth during the forecast period. Factors such as the high demand potential of automated analyzers in blood banks and next-generation immunohematology analyzers with better throughput will significantly influence the growth of the immunohematology analyzer and system market. Several market players in the market are focusing on developing next-generation immunohematology analyzers with improved speed, performance, and automation. 

Get a glance at the market contribution of various segments View a PDF Sample

The analyzers and systems segment was the largest segment and was valued at USD 1.20 billion in 2017. For instance, Immucor developed NEO that targets Tier 1 hospitals and reference laboratories. The main advantage of this analyzer is that it can process 224 test samples at the same time and offer a broad test menu for the recipient and donor. There is a growing prominence for automated immunohematology analyzers due to their high potential for manual blood bank testing replacement. As a result, the analyzer is being considered an ideal option as well as a possible replacement for traditionally performed manual methods in blood bank testing. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

End-user Analysis 

One of the largest end-user segments for the market is the hospitals, including multispecialty hospitals and hospital groups, which work under government sponsorship or through private entities. Some of these hospitals can accommodate more than 500 individual patients within their locality.  These hospitals provide a large number of inpatient and outpatient services such that diagnosis and monitoring of most surgical events are conducted in outpatient settings. Hence, the demand for immunohematology analyzers, instruments, and reagents is fuelled by the increased number of hospital admissions for surgical care. Thus such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main reasons for the market in North America is factors such as the rising number of hospital-acquired infections (HAIs) in individuals. Additionally, there is an increasing need for blood in surgical procedures including general surgery or organ transplantation. One of the main dominant markets in North America in the market is the US. As per the CDC, in the US, 3.2% of patients suffer from at least one hospital-acquired infection (HAI) in a day. Some of the conditions in HAIs include pneumonia, bloodstream-related infections, and other types of infections. There are several government initiatives to spread awareness of the Affordable Care Act (ACT) for medical safety has significantly contributed to the market growth. Hence, such factors are expected to drive the market in the region during the forecast period.

Buy Now Full Report and Discover More

Market Dynamics and Customer Landscape

The Immunohematology Market is experiencing robust growth due to rising demand for blood donations and immunohematology testing. As blood donations serve as the primary source for transfusion, ensuring compatibility through immunohematology testing is essential for patient safety. This market is witnessing significant traction driven by advancements in technology, including automated immunohematology instruments, which enhance accuracy and efficiency in testing processes. Key players like Ortho Clinical Diagnostics and Grifols are offering a diverse range of products and solutions, addressing the increasing prevalence of blood-related disorders and the need for blood transfusions. However, challenges persist, such as the high cost of products, particularly in developing regions. Despite this, the market is forecasted to grow substantially, fueled by the continuous emphasis on blood transfusion safety and the growing adoption of immunohematology testing worldwide. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Market Drivers

One of the key factors driving the market growth is the growing demand for blood banks and their potential to increase sales. There is an increasing demand for blood banks across the world. These blood banks collect and store blood from donors by utilizing a bloodmobile or the donors can visit the centers for blood donation. It is then transfused to many screening tests, including screening for infectious disease and blood typing, and serological tests for blood plasma.

Moreover, one of the important aspects in the market is cord blood banking. Once the cord blood is donated, the blood bank preserves it after subjecting it to several tests, including immunohematology. Hence, the growing demand for blood components and cord blood for storage in the blood bank and transfusion is expected to drive the market during the forecast period.

Significant Market Trends

A key factor shaping the market growth is the paradigm shift toward molecular immunohematology. One of the main methods that help in the identification of the molecular and genetic basis of any antigen is molecular analysis. The main advantage of this method is that it helps clinicians understand the molecular basis of blood group antigens and blood typing.

Additionally, there is a growing popularity for this method as it is the ideal method to understand the cross-matching of donor and recipient blood. Furthermore, there is an increasing adoption of molecular immunohematology along with serological typing and HLA typing across many blood banks and hospitals. Hence, such factors are expected to drive the market during the forecast period.

Major Market Challenges

High maintenance costs and low reimbursement for blood components are one of the key challenges hindering market growth. There is an increasing cost burden on blood banks due to the increasing cost of the maintenance of blood components associated with labor cost, reagents and disposables cost, and storage. For instance, the average cost of cord blood handling is around USD 1,500 per year.

As a result, several public and private blood banks enforce a charge for registration and ask for an annual charge from donors. Furthermore, there is low adoption of these products due to low reimbursements. For example, if the cost of the RBC unit is around USD150-USD165, the reimbursed amount comprises only USD75-USD80. Hence, such factors are expected to hinder the market during the forecast period.

Buy Now Full Report and Discover More

Customer Landscape

The market growth and forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Key Immunohematology Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market growth analysis report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Becton Dickinson and Co: The company offers several immunohematology products, such as BD Vacutainer serum tubes and BD Vacutainer EDTA tubes among others.

  • Biomed Global
  • Bio Rad Laboratories Inc.
  • biosurfit SA
  • Cardinal Health Inc.
  • Danaher Corp.
  • DIAGAST SAS
  • Grifols SA
  • Hemo bioscience Inc.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Institut de Biotechnologies Jacques Boy
  • MAK SYSTEM S.A.
  • Merck KGaA
  • Mesa Laboratories Inc.
  • Quotient Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Tulip Diagnostics Pvt. Ltd.
  • Werfenlife SA
  •  Calibre Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing growth driven by factors like increased blood donations, rising demand for immunohematology testing, and a surge in elective surgical procedures. Technological advancements and the development of new products are also contributing to market expansion. Blood-related disorders, such as hemophilia, sickle cell disease, and blood cancer, are fueling the demand for hematological testing. Furthermore, the high burden of leukemia and other blood disorders necessitates advanced hematology analyzers for accurate results. Despite challenges like the high cost of products and shortage of skilled personnel, rising adoption rates of automated immunohematology instruments and increasing government initiatives are expected to drive market progression. With continuous research and development efforts, the Immunohematology Market is poised for further growth, catering to the increasing prevalence of hematological disorders globally.

Segment Overview

The market forecasting report covers market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook 
    • Analyzers and systems
    • Reagents
  • End-user Outlook
    • Hospitals
    • Blood banks
    • Diagnostic laboratories
  • Geography Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Brazil
      • Australia

Immunohematology Market Scope

Market Report Coverage

Details

Page number

160

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.06%

Market growth 2023-2027

USD 1.27 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

6.44

Regional analysis

North America, Europe, Asia, and Rest of the World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Becton Dickinson and Co., Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., Werfenlife SA, and Calibre Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the global market between 2023 and 2027
  • Precise estimation of the market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global immunohematology market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global immunohematology market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Analyzers and systems - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Analyzers and systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Analyzers and systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Analyzers and systems - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Analyzers and systems - Year-over-year growth 2022-2027 (%)
    • 6.4 Reagents - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Reagents - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Reagents - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Reagents - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
    • 7.4 Blood banks - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Blood banks - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Blood banks - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Blood banks - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Blood banks - Year-over-year growth 2022-2027 (%)
    • 7.5 Diagnostic laboratories - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ million)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Becton Dickinson and Co.
              • Exhibit 111: Becton Dickinson and Co. - Overview
              • Exhibit 112: Becton Dickinson and Co. - Business segments
              • Exhibit 113: Becton Dickinson and Co. - Key news
              • Exhibit 114: Becton Dickinson and Co. - Key offerings
              • Exhibit 115: Becton Dickinson and Co. - Segment focus
            • 12.4 Bio Rad Laboratories Inc.
              • Exhibit 116: Bio Rad Laboratories Inc. - Overview
              • Exhibit 117: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 118: Bio Rad Laboratories Inc. - Key news
              • Exhibit 119: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 120: Bio Rad Laboratories Inc. - Segment focus
            • 12.5 biosurfit SA
              • Exhibit 121: biosurfit SA - Overview
              • Exhibit 122: biosurfit SA - Product / Service
              • Exhibit 123: biosurfit SA - Key offerings
            • 12.6 Cardinal Health Inc.
              • Exhibit 124: Cardinal Health Inc. - Overview
              • Exhibit 125: Cardinal Health Inc. - Business segments
              • Exhibit 126: Cardinal Health Inc. - Key news
              • Exhibit 127: Cardinal Health Inc. - Key offerings
              • Exhibit 128: Cardinal Health Inc. - Segment focus
            • 12.7 Danaher Corp.
              • Exhibit 129: Danaher Corp. - Overview
              • Exhibit 130: Danaher Corp. - Business segments
              • Exhibit 131: Danaher Corp. - Key news
              • Exhibit 132: Danaher Corp. - Key offerings
              • Exhibit 133: Danaher Corp. - Segment focus
            • 12.8 DIAGAST SAS
              • Exhibit 134: DIAGAST SAS - Overview
              • Exhibit 135: DIAGAST SAS - Product / Service
              • Exhibit 136: DIAGAST SAS - Key offerings
            • 12.9 Grifols SA
              • Exhibit 137: Grifols SA - Overview
              • Exhibit 138: Grifols SA - Business segments
              • Exhibit 139: Grifols SA - Key offerings
              • Exhibit 140: Grifols SA - Segment focus
            • 12.10 Hemo bioscience Inc.
              • Exhibit 141: Hemo bioscience Inc. - Overview
              • Exhibit 142: Hemo bioscience Inc. - Product / Service
              • Exhibit 143: Hemo bioscience Inc. - Key offerings
            • 12.11 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
              • Exhibit 144: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
              • Exhibit 145: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
              • Exhibit 146: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
            • 12.12 Institut de Biotechnologies Jacques Boy
              • Exhibit 147: Institut de Biotechnologies Jacques Boy - Overview
              • Exhibit 148: Institut de Biotechnologies Jacques Boy - Product / Service
              • Exhibit 149: Institut de Biotechnologies Jacques Boy - Key offerings
            • 12.13 MAK SYSTEM S.A.
              • Exhibit 150: MAK SYSTEM S.A. - Overview
              • Exhibit 151: MAK SYSTEM S.A. - Product / Service
              • Exhibit 152: MAK SYSTEM S.A. - Key offerings
            • 12.14 Merck KGaA
              • Exhibit 153: Merck KGaA - Overview
              • Exhibit 154: Merck KGaA - Business segments
              • Exhibit 155: Merck KGaA - Key news
              • Exhibit 156: Merck KGaA - Key offerings
              • Exhibit 157: Merck KGaA - Segment focus
            • 12.15 Mesa Laboratories Inc.
              • Exhibit 158: Mesa Laboratories Inc. - Overview
              • Exhibit 159: Mesa Laboratories Inc. - Business segments
              • Exhibit 160: Mesa Laboratories Inc. - Key offerings
              • Exhibit 161: Mesa Laboratories Inc. - Segment focus
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 162: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 164: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 Werfenlife SA
              • Exhibit 167: Werfenlife SA - Overview
              • Exhibit 168: Werfenlife SA - Product / Service
              • Exhibit 169: Werfenlife SA - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 170: Inclusions checklist
                • Exhibit 171: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 172: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 173: Research methodology
                • Exhibit 174: Validation techniques employed for market sizing
                • Exhibit 175: Information sources
              • 13.5 List of abbreviations
                • Exhibit 176: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              immunohematology market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis